D'Alessandro A, Zolla L: Metabolomics and cancer drug discovery: let the cells do the talking. Drug Discov Today. 2012, 17: 3-9. 10.1016/j.drudis.2011.09.017.
Article
PubMed
Google Scholar
Bading JR, Shields AF: Imaging of cell proliferation: status and prospects. J Nucl Med. 2008, 49 (Suppl 2): 64S-80S.
Article
CAS
PubMed
Google Scholar
Rasey JS, Grierson JR, Wiens LW, Kolb PD, Schwartz JL: Validation of FLT uptake as a measure of thymidine kinase-1 activity in A549 carcinoma cells. J Nucl Med. 2002, 43: 1210-1217.
CAS
PubMed
Google Scholar
Grierson JR, Schwartz JL, Muzi M, Jordan R, Krohn KA: Metabolism of 3′-deoxy-3′-[F-18]fluorothymidine in proliferating A549 cells: validations for positron emission tomography. Nucl Med Biol. 2004, 31: 829-837. 10.1016/j.nucmedbio.2004.06.004.
Article
CAS
PubMed
Google Scholar
Shields AF, Grierson JR, Dohmen BM, Machulla HJ, Stayanoff JC, Lawhorn-Crews JM, Obradovich JE, Muzik O, Mangner TJ: Imaging proliferation in vivo with [F-18]FLT and positron emission tomography. Nat Med. 1998, 4: 1334-1336. 10.1038/3337.
Article
CAS
PubMed
Google Scholar
Mikulits W, Hengstschlager M, Sauer T, Wintersberger E, Mullner EW: Overexpression of thymidine kinase mRNA eliminates cell cycle regulation of thymidine kinase enzyme activity. J Biol Chem. 1996, 271: 853-860. 10.1074/jbc.271.2.853.
Article
CAS
PubMed
Google Scholar
Sherley JL, Kelly TJ: Regulation of human thymidine kinase during the cell cycle. J Biol Chem. 1988, 263: 8350-8358.
CAS
PubMed
Google Scholar
Toyohara J, Waki A, Takamatsu S, Yonekura Y, Magata Y, Fujibayashi Y: Basis of FLT as a cell proliferation marker: comparative uptake studies with [3H]thymidine and [3H]arabinothymidine, and cell-analysis in 22 asynchronously growing tumor cell lines. Nucl Med Biol. 2002, 29: 281-287. 10.1016/S0969-8051(02)00286-X.
Article
PubMed
Google Scholar
Direcks WG, Berndsen SC, Proost N, Peters GJ, Balzarini J, Spreeuwenberg MD, Lammertsma AA: Molthoff CF: [18F]FDG and [18F]FLT uptake in human breast cancer cells in relation to the effects of chemotherapy: an in vitro study. Br J Cancer. 2008, 99: 481-487. 10.1038/sj.bjc.6604523.
Article
PubMed Central
CAS
PubMed
Google Scholar
Contractor KB, Kenny LM, Stebbing J, Rosso L, Ahmad R, Jacob J, Challapalli A, Turkheimer F, Al-Nahhas A, Sharma R, Coombes RC, Aboagye EO: [18F]-3′deoxy-3′-Fluorothymidine Positron Emission Tomography and Breast Cancer Response to Docetaxel. Clin Cancer Res. 2011, 17: 7664-7672. 10.1158/1078-0432.CCR-11-0783.
Article
CAS
PubMed
Google Scholar
Li W, Araya M, Elliott M, Kang X, Gerk PM, Halquist MS, Karnes HT, Zhang C, O'Brien PJ: Monitoring cellular accumulation of 3′-deoxy-3′-fluorothymidine (FLT) and its monophosphate metabolite (FLT-MP) by LC-MS/MS as a measure of cell proliferation in vitro. J Chromatogr B Analyt Technol Biomed Life Sci. 2011, 879: 2963-2970. 10.1016/j.jchromb.2011.08.024.
Article
CAS
PubMed
Google Scholar
Zhang CC, Yan Z, Li W, Kuszpit K, Painter CL, Zhang Q, Lappin PB, Nichols T, Lira ME, Affolter T, Fahey NR, Cullinane C, Spilker M, Zasadny K, O'Brien P, Buckman D, Wong A, Christensen JG: [18F]FLT-PET imaging does not always “light up” proliferating tumor cells. Clin Cancer Res. 2012, 18: 1303-1312. 10.1158/1078-0432.CCR-11-1433.
Article
CAS
PubMed
Google Scholar
Ramanathan A, Schreiber SL: Direct control of mitochondrial function by mTOR. Proc Natl Acad Sci USA. 2009, 106: 22229-22232. 10.1073/pnas.0912074106.
Article
PubMed Central
CAS
PubMed
Google Scholar
Reyzer ML, Caprioli RM: MALDI-MS-based imaging of small molecules and proteins in tissues. Curr Opin Chem Biol. 2007, 11: 29-35. 10.1016/j.cbpa.2006.11.035.
Article
CAS
PubMed
Google Scholar
Northen TR, Yanes O, Northen MT, Marrinucci D, Uritboonthai W, Apon J, Golledge SL, Nordstrom A, Siuzdak G: Clathrate nanostructures for mass spectrometry. Nature. 2007, 449: 1033-1036. 10.1038/nature06195.
Article
CAS
PubMed
Google Scholar
Schwamborn K, Caprioli RM: Molecular imaging by mass spectrometry–looking beyond classical histology. Nat Rev Cancer. 2010, 10: 639-646. 10.1038/nrc2917.
Article
CAS
PubMed
Google Scholar
Li L, Garden RW, Sweedler JV: Single-cell MALDI: a new tool for direct peptide profiling. Trends Biotechnol. 2000, 18: 151-160. 10.1016/S0167-7799(00)01427-X.
Article
CAS
PubMed
Google Scholar
Rubakhin SS, Romanova EV, Nemes P, Sweedler JV: Profiling metabolites and peptides in single cells. Nat Methods. 2011, 8: S20-S29. 10.1038/nmeth.1549.
Article
PubMed Central
CAS
PubMed
Google Scholar
Northen TR, Lee JC, Hoang L, Raymond J, Hwang DR, Yannone SM, Wong C, Siuzdak G: A nanostructure-initiator mass spectrometry-based enzyme activity assay. Proc Natl Acad Sci USA. 2008, 105: 3678-10.1073/pnas.0712332105.
Article
PubMed Central
CAS
PubMed
Google Scholar
Greving MP, Patti GJ, Siuzdak G: Nanostructure-Initiator Mass Spectrometry Metabolite Analysis and Imaging. Anal Chem. 2010, 83: 2-7.
Article
PubMed Central
PubMed
Google Scholar
Patti GJ, Shriver LP, Wassif CA, Woo HK, Uritboonthai W, Apon J, Manchester M, Porter FD, Siuzdak G: Nanostructure-initiator mass spectrometry (NIMS) imaging of brain cholesterol metabolites in Smith-Lemli-Opitz syndrome. Neuroscience. 2010, 170: 858-864. 10.1016/j.neuroscience.2010.07.038.
Article
PubMed Central
CAS
PubMed
Google Scholar
Hsieh Y, Chen J, Korfmacher WA: Mapping pharmaceuticals in tissues using MALDI imaging mass spectrometry. J Pharmacol Toxicol Methods. 2007, 55: 193-200. 10.1016/j.vascn.2006.06.004.
Article
CAS
PubMed
Google Scholar
Smith CA, Want EJ, O'Maille G, Abagyan R, Siuzdak G: XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal Chem. 2006, 78: 779-787. 10.1021/ac051437y.
Article
CAS
PubMed
Google Scholar
Smith CA, O'Maille G, Want EJ, Qin C, Trauger SA, Brandon TR, Custodio DE, Abagyan R, Siuzdak G: METLIN: a metabolite mass spectral database. Ther Drug Monit. 2005, 27: 747-751. 10.1097/01.ftd.0000179845.53213.39.
Article
CAS
PubMed
Google Scholar
Woo HK, Northen TR, Yanes O, Siuzdak G: Nanostructure-initiator mass spectrometry: a protocol for preparing and applying NIMS surfaces for high-sensitivity mass analysis. Nat Protoc. 2008, 3: 1341-1349. 10.1038/nprot.2008.110.
Article
CAS
PubMed
Google Scholar
Brockenbrough JS, Souquet T, Morihara JK, Stern JE, Hawes SE, Rasey JS, Leblond A, Wiens LW, Feng Q, Grierson J, Vesselle H: Tumor 3′-deoxy-3′-(18)F-fluorothymidine ((18)F-FLT) uptake by PET correlates with thymidine kinase 1 expression: static and kinetic analysis of (18)F-FLT PET studies in lung tumors. J Nucl Med. 2011, 52: 1181-1188. 10.2967/jnumed.111.089482.
Article
PubMed
Google Scholar
Plotnik DA, McLaughlin LJ, Chan J, Redmayne-Titley JN, Schwartz JL: The role of nucleoside/nucleotide transport and metabolism in the uptake and retention of 3′-fluoro-3′-deoxythymidine in human B-lymphoblast cells. Nucl Med Biol. 2011, 38: 979-986. 10.1016/j.nucmedbio.2011.03.009.
Article
PubMed Central
CAS
PubMed
Google Scholar
Plotnik DA, Emerick LE, Krohn KA, Unadkat JD, Schwartz JL: Different modes of transport for 3H-thymidine, 3H-FLT, and 3H-FMAU in proliferating and nonproliferating human tumor cells. J Nucl Med. 2010, 51: 1464-1471. 10.2967/jnumed.110.076794.
Article
PubMed Central
CAS
PubMed
Google Scholar
Buck AK, Kratochwil C, Glatting G, Juweid M, Bommer M, Tepsic D, Vogg AT, Mattfeldt T, Neumaier B, Moller P, Reske SN: Early assessment of therapy response in malignant lymphoma with the thymidine analogue [18F]FLT. Eur J Nucl Med Mol Imaging. 2007, 34: 1775-1782. 10.1007/s00259-007-0452-z.
Article
CAS
PubMed
Google Scholar
Zhang F, Shao X, Li H, Robison JG, Murray BK, O'Neill KL: A monoclonal antibody specific for human thymidine kinase 1. Hybridoma. 2001, 20: 25-34. 10.1089/027245701300060382.
Article
PubMed
Google Scholar
Kong XB, Zhu QY, Vidal PM, Watanabe KA, Polsky B, Armstrong D, Ostrander M, Lang SA, Muchmore E, Chou TC: Comparisons of anti-human immunodeficiency virus activities, cellular transport, and plasma and intracellular pharmacokinetics of 3′-fluoro-3′-deoxythymidine and 3′-azido-3′-deoxythymidine. Antimicrob Agents Chemother. 1992, 36: 808-818. 10.1128/AAC.36.4.808.
Article
PubMed Central
CAS
PubMed
Google Scholar
Mansuri MM, Hitchcock MJ, Buroker RA, Bregman CL, Ghazzouli I, Desiderio JV, Starrett JE, Sterzycki RZ, Martin JC: Comparison of in vitro biological properties and mouse toxicities of three thymidine analogs active against human immunodeficiency virus. Antimicrob Agents Chemother. 1990, 34: 637-641. 10.1128/AAC.34.4.637.
Article
PubMed Central
CAS
PubMed
Google Scholar
Kameyama R, Yamamoto Y, Izuishi K, Sano T, Nishiyama Y: Correlation of 18F-FLT uptake with equilibrative nucleoside transporter-1 and thymidine kinase-1 expressions in gastrointestinal cancer. Nucl Med Commun. 2011, 32: 460-465. 10.1097/MNM.0b013e32834209b5.
Article
CAS
PubMed
Google Scholar
Paproski RJ, Wuest M, Jans HS, Graham K, Gati WP, McQuarrie S, McEwan A, Mercer J, Young JD, Cass CE: Biodistribution and uptake of 3′-deoxy-3′-fluorothymidine in ENT1-knockout mice and in an ENT1-knockdown tumor model. J Nucl Med. 2010, 51: 1447-1455. 10.2967/jnumed.110.076356.
Article
CAS
PubMed
Google Scholar
Bekaii-Saab TS, Villalona-Calero MA: Preclinical experience with docetaxel in gastrointestinal cancers. Semin Oncol. 2005, 32: S3-S9.
Article
CAS
PubMed
Google Scholar
Munch-Petersen B, Cloos L, Tyrsted G, Eriksson S: Diverging substrate specificity of pure human thymidine kinases 1 and 2 against antiviral dideoxynucleosides. J Biol Chem. 1991, 266: 9032-9038.
CAS
PubMed
Google Scholar
Corban-Wilhelm H, Ehemann V, Becker G, Greulich D, Braun K, Debus J: Comparison of different methods to assess the cytotoxic effects of cytosine deaminase and thymidine kinase gene therapy. Cancer Gene Ther. 2004, 11: 208-214. 10.1038/sj.cgt.7700667.
Article
CAS
PubMed
Google Scholar
Zhang CC, Yan Z, Painter CL, Zhang Q, Chen E, Arango ME, Kuszpit K, Zasadny K, Hallin M, Hallin J, Wong A, Buckman D, Sun G, Qiu M, Anderes K, Christensen JG: PF-00477736 mediates checkpoint kinase 1 signaling pathway and potentiates docetaxel-induced efficacy in xenografts. Clin Cancer Res. 2009, 15: 4630-4640. 10.1158/1078-0432.CCR-08-3272.
Article
CAS
PubMed
Google Scholar
Zhang CC, Yan Z, Zhang Q, Kuszpit K, Zasadny K, Qiu M, Painter CL, Wong A, Kraynov E, Arango ME, Mehta PP, Popoff I, Casperson GF, Los G, Bender S, Anderes K, Christensen JG, VanArsdale T: PF-03732010: a fully human monoclonal antibody against P-cadherin with antitumor and antimetastatic activity. Clin Cancer Res. 2010, 16: 5177-5188. 10.1158/1078-0432.CCR-10-1343.
Article
CAS
PubMed
Google Scholar
Nguyen L, Zhong WZ, Painter CL, Zhang C, Rahavendran SV, Shen Z: Quantitative analysis of PD 0332991 in xenograft mouse tumor tissue by a 96-well supported liquid extraction format and liquid chromatography/mass spectrometry. J Pharm Biomed Anal. 2010, 53: 228-234. 10.1016/j.jpba.2010.02.031.
Article
CAS
PubMed
Google Scholar
Toyohara J, Ishiwata K: Animal tumor models for PET in drug development. Ann Nucl Med. 2011, 25: 717-731. 10.1007/s12149-011-0531-x.
Article
PubMed
Google Scholar
Morse DL, Gray H, Payne CM, Gillies RJ: Docetaxel induces cell death through mitotic catastrophe in human breast cancer cells. Mol Cancer Ther. 2005, 4: 1495-1504. 10.1158/1535-7163.MCT-05-0130.
Article
CAS
PubMed
Google Scholar
Morse DL, Raghunand N, Sadarangani P, Murthi S, Job C, Day S, Howison C, Gillies RJ: Response of choline metabolites to docetaxel therapy is quantified in vivo by localized (31)P MRS of human breast cancer xenografts and in vitro by high-resolution (31)P NMR spectroscopy of cell extracts. Magn Reson Med. 2007, 58: 270-280. 10.1002/mrm.21333.
Article
CAS
PubMed
Google Scholar
Morse DL, Galons JP, Payne CM, Jennings DL, Day S, Xia G, Gillies RJ: MRI-measured water mobility increases in response to chemotherapy via multiple cell-death mechanisms. NMR Biomed. 2007, 20: 602-614. 10.1002/nbm.1127.
Article
CAS
PubMed
Google Scholar
Morse DL, Carroll D, Day S, Gray H, Sadarangani P, Murthi S, Job C, Baggett B, Raghunand N, Gillies RJ: Characterization of breast cancers and therapy response by MRS and quantitative gene expression profiling in the choline pathway. NMR Biomed. 2009, 22: 114-127. 10.1002/nbm.1318.
Article
PubMed Central
CAS
PubMed
Google Scholar
Hickson J, Ackler S, Klaubert D, Bouska J, Ellis P, Foster K, Oleksijew A, Rodriguez L, Schlessinger S, Wang B, Frost D: Noninvasive molecular imaging of apoptosis in vivo using a modified firefly luciferase substrate, Z-DEVD-aminoluciferin. Cell Death Differ. 2010, 17: 1003-1010. 10.1038/cdd.2009.205.
Article
CAS
PubMed
Google Scholar
Viertl D, Bischof Delaloye A, Lanz B, Poitry-Yamate C, Gruetter R, Mlynarik V, Ametamey SM, Ross TL, Lehr HA, André PA, Perillo-Adamer F, Kosinski M, Dupertuis YM, Buchegger F: Increase of [(18)F]FLT tumor uptake in vivo mediated by FdUrd: toward improving cell proliferation positron emission tomography. Mol Imaging Biol. 2011, 13: 321-331. 10.1007/s11307-010-0368-z.
Article
PubMed
Google Scholar
Jenkins DE, Hornig YS, Oei Y, Dusich J, Purchio T: Bioluminescent human breast cancer cell lines that permit rapid and sensitive in vivo detection of mammary tumors and multiple metastases in immune deficient mice. Breast Cancer Res. 2005, 7: R444-R454. 10.1186/bcr1026.
Article
PubMed Central
CAS
PubMed
Google Scholar
Alauddin MM, Gelovani JG: Pyrimidine nucleosides in molecular PET imaging of tumor proliferation. Curr Med Chem. 2010, 17: 1010-1029. 10.2174/092986710790820606.
Article
CAS
PubMed
Google Scholar
Al-Madhoun AS, Tjarks W, Eriksson S: The role of thymidine kinases in the activation of pyrimidine nucleoside analogues. Mini Rev Med Chem. 2004, 4: 341-350.
Article
CAS
PubMed
Google Scholar
O'Neill KL, Buckwalter MR, Murray BK: Thymidine kinase: diagnostic and prognostic potential. Expert Rev Mol Diagn. 2001, 1: 428-433. 10.1586/14737159.1.4.428.
Article
PubMed
Google Scholar
Krohn KA, Mankoff DA, Eary JF: Imaging cellular proliferation as a measure of response to therapy. J Clin Pharmacol. 2001, 96S-103S. Suppl
Hannigan BM, Barnett YA, Armstrong DB, McKelvey-Martin VJ, McKenna PG: Thymidine kinases: the enzymes and their clinical usefulness. Cancer Biother. 1993, 8: 189-197. 10.1089/cbr.1993.8.189.
Article
CAS
PubMed
Google Scholar
O'Dwyer PJ, King SA, Hoth DF, Leyland-Jones B: Role of thymidine in biochemical modulation: a review. Cancer Res. 1987, 47: 3911-3919.
PubMed
Google Scholar
Tehrani OS, Douglas KA, Lawhorn-Crews JM, Shields AF: Tracking cellular stress with labeled FMAU reflects changes in mitochondrial TK2. Eur J Nucl Med Mol Imaging. 2008, 35: 1480-1488. 10.1007/s00259-008-0738-9.
Article
CAS
PubMed
Google Scholar
Barthel H, Perumal M, Latigo J, He Q, Brady F, Luthra SK, Price PM, Aboagye EO: The uptake of 3′-deoxy-3′-[18F]fluorothymidine into L5178Y tumours in vivo is dependent on thymidine kinase 1 protein levels. Eur J Nucl Med Mol Imaging. 2005, 32: 257-263. 10.1007/s00259-004-1611-0.
Article
CAS
PubMed
Google Scholar
Toyohara J, Hayashi A, Gogami A, Fujibayashi Y: Alkyl-fluorinated thymidine derivatives for imaging cell proliferation II. Synthesis and evaluation of N3-(2-[18F]fluoroethyl)-thymidine. Nucl Med Biol. 2006, 33: 765-772. 10.1016/j.nucmedbio.2006.06.001.
Article
CAS
PubMed
Google Scholar
Franzolin E, Rampazzo C, Perez-Perez MJ, Hernandez AI, Balzarini J, Bianchi V: Bromovinyl-deoxyuridine: A selective substrate for mitochondrial thymidine kinase in cell extracts. Biochem Biophys Res Commun. 2006, 344: 30-36. 10.1016/j.bbrc.2006.03.147.
Article
CAS
PubMed
Google Scholar
Dorow DS, Cullinane C, Conus N, Roselt P, Binns D, McCarthy TJ, McArthur GA, Hicks RJ: Multi-tracer small animal PET imaging of the tumour response to the novel pan-Erb-B inhibitor CI-1033. Eur J Nucl Med Mol Imaging. 2006, 33: 441-452. 10.1007/s00259-005-0039-5.
Article
PubMed
Google Scholar
Atkinson DM, Clarke MJ, Mladek AC, Carlson BL, Trump DP, Jacobson MS, Kemp BJ, Lowe VJ, Sarkaria JN: Using fluorodeoxythymidine to monitor anti-EGFR inhibitor therapy in squamous cell carcinoma xenografts. Head Neck. 2008, 30: 790-799. 10.1002/hed.20770.
Article
PubMed Central
PubMed
Google Scholar
Olofsson S, Eriksson S, Karlsson A, Oberg B: The HIV replication inhibitor 3′-fluoro-3′-deoxythymidine blocks sialylation of N-linked oligosaccharides. Antiviral Res. 1992, 19: 71-80. 10.1016/0166-3542(92)90057-C.
Article
CAS
PubMed
Google Scholar
McGrogan BT, Gilmartin B, Carney DN, McCann A: Taxanes, microtubules and chemoresistant breast cancer. Biochim Biophys Acta. 2008, 1785: 96-132.
CAS
PubMed
Google Scholar
Hennequin C, Giocanti N, Favaudon V: S-phase specificity of cell killing by docetaxel (Taxotere) in synchronised HeLa cells. Br J Cancer. 1995, 71: 1194-1198. 10.1038/bjc.1995.232.
Article
PubMed Central
CAS
PubMed
Google Scholar
Hunsucker SA, Mitchell BS, Spychala J: The 5′-nucleotidases as regulators of nucleotide and drug metabolism. Pharmacol Ther. 2005, 107: 1-30. 10.1016/j.pharmthera.2005.01.003.
Article
CAS
PubMed
Google Scholar